C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/31/2002	WO2001053342A9 Chimeric prostate-homing peptides with pro-apoptotic activity
10/31/2002	WO2001053335A9 Peptides with antibacterial activity
10/31/2002	WO2001051633A9 Compositions and methods for the therapy and diagnosis of prostate cancer
10/31/2002	WO2001051632A9 Odorant receptor polypeptides and nucleic acids encoding same
10/31/2002	WO2001049844A9 Compositions and methods for gene silencing
10/31/2002	WO2001047962A8 Attenuated microorganisms for the treatment of infection
10/31/2002	WO2001036478A3 Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides
10/31/2002	US20020162142 Genes and methods for manipulation of growth
10/31/2002	US20020162141 Selecting a target plant and transgene DNA molecule; constructing a plasmid; transforming an embryonic calli of target plant with tungsten particles coated with plasmid; culturing bombarded calli on a tissue culture medium
10/31/2002	US20020162139 Maize metallothionein gene and promoter
10/31/2002	US20020162133 Useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions
10/31/2002	US20020162131 Useful as models for disease and for identifying agents that modulate gene expression and gene function, and as potential treatments for various disease states and disease conditions
10/31/2002	US20020162129 Prevention and treatment of alzheimer's disease
10/31/2002	US20020162128 Model animal for psychiatric disorders
10/31/2002	US20020162127 For use in diagnostic, therapeutic, and investigational procedures
10/31/2002	US20020162123 For therapy of tumors
10/31/2002	US20020161218 For immunizing
10/31/2002	US20020161217 DNA encoding orphan SNORF40 receptor
10/31/2002	US20020161216 DNA encoding orphan SNORF4 receptor
10/31/2002	US20020161215 For use in assays designed to identify and characterize compounds which affect the function of such receptors, e.g., agonists and antagonists of NMDA receptors
10/31/2002	US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002	US20020161211 Compositions, methods and kits relating to REMODELIN
10/31/2002	US20020161210 Compositions, methods, and kits relating to resistin
10/31/2002	US20020161207 Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
10/31/2002	US20020161204 Methods of detecting a liver disorder
10/31/2002	US20020161203 Rattlesnake venom gland proteins
10/31/2002	US20020161202 For modulating apoptosis in mammalian cells
10/31/2002	US20020161201 For use in cancer diagnosis and therapy
10/31/2002	US20020161200 For therapy
10/31/2002	US20020161199 Compositions and methods for the diagnosis and treatment of tumor
10/31/2002	US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002	US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002	US20020161194 Cannine androgen receptor
10/31/2002	US20020161193 Useful for the production of NMDA receptor subunit proteins, these nucleic acids are also useful as probes, to identify and isolate related human receptor subunits
10/31/2002	US20020161192 Helicobacter pylori live vaccine
10/31/2002	US20020161191 Novel Imidazoline receptor homologs
10/31/2002	US20020161190 Method of identifying cells expressing a protein having pre-B cell growth-supporting ability
10/31/2002	US20020161178 Novel DKR polypeptides
10/31/2002	US20020160977 Method for selective inactivation of viral replication
10/31/2002	US20020160976 Method for selective inactivation of viral replication
10/31/2002	US20020160972 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
10/31/2002	US20020160971 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor
10/31/2002	US20020160960 Human leukocyte antigen/major histocompatibility complex (HLA); given amino acid sequence; useful to elicit an immune response against a desired antigen
10/31/2002	US20020160959 Therapeutic compounds for ovarian cancer
10/31/2002	US20020160957 Treating tumors
10/31/2002	US20020160955 Protein variants
10/31/2002	US20020160954 Polynucleotides; Interphotoreceptor matrix component (IPMC) gene family; treating eye disorders
10/31/2002	US20020160953 Mammalian glycoprotein hormone-1
10/31/2002	US20020160952 Tri-peptide fusion proteins with domains that bind proteins with repeating glutamine residues; treating disorders such as Huntington's disease associated with expanded CAG repeats
10/31/2002	US20020160949 Nucleic acid encoding the receptor; use drug screening
10/31/2002	US20020160948 Such as preventing or treating primary cancer cell growth
10/31/2002	US20020160944 Which contain multiple beta subunits of the hormones luteinizing hormone (LH), follicle stimulating hormone (FSH), chorionic gonadotropin (CG), and/or thyroid stimulating hormone coupled to the a subunit; use enhancing fertility
10/31/2002	US20020160941 Treating compositions with lactoferrin
10/31/2002	US20020160940 Modulation of endogenous gene expression in cells
10/31/2002	US20020160938 At least one is a human or animal insulin analogue; coupled together with a diacid such as by reacting with suberic acid, bis(N-hydroxysuccinimidyl) ester
10/31/2002	US20020160937 Human vitreous and pharmaceutical compositions
10/31/2002	US20020160936 Hepatitis C virus envelope E2 protein (HCV E2); inhibiting the attachment of hepatitis C virus onto cells
10/31/2002	US20020160934 Nucleic acid sequences from Drosophila melanogaster that encode proteins essential for larval viability and uses thereof
10/31/2002	US20020160915 Altering the ATP gradient across the membrane of a target cell by inhibiting an extracellular phosphatase (ecto-phosphatase) in the target cell
10/31/2002	US20020160516 Useful to the pharmaceutical and biotechnology industries
10/31/2002	US20020160512 Culturing isolated hematopoietic stem cells (HSC) in culture system comprising culture medium in presence of stem cell expansion promoting factor (SCEPF) which is produced by culturing murine stromal cells
10/31/2002	US20020160508 Fibrin polymer structure
10/31/2002	US20020160502 For use in immunotherapy
10/31/2002	US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002	US20020160500 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203
10/31/2002	US20020160498 Can be used, for example, as target molecules for developing drugs against cancer
10/31/2002	US20020160497 For use in detection and treatment of the disease, breast cancer, prostate cancer, testicular cancer, ovarian cancer, uterine cancer cervical cancer, and colon cancer
10/31/2002	US20020160496 Diagnosis and treatment of disorders related to Hsp90 protein function
10/31/2002	US20020160495 Soluble ischemia activated protein
10/31/2002	US20020160494 Tendon-inducing compositions
10/31/2002	US20020160491 For diagnosis, prophylaxis and therapy of cancer, inflammation, neurological disorders and immune diseases and/or disorders
10/31/2002	US20020160490 For screening physiologically active substances using serine protease or DNA that codes for it
10/31/2002	US20020160488 For therapy and prophylaxis of cell proliferation disorders, autoimmune/inflammatory disorders, and vesicle trafficking disorders
10/31/2002	US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002	US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002	US20020160477 CAF1-related protein
10/31/2002	US20020160476 Genetic engineeering; binding to antibodies
10/31/2002	US20020160475 Novel human ion channel protein and polynucleotides encoding the same
10/31/2002	US20020160474 Adipocyte complement related protein zacrp11
10/31/2002	US20020160473 Far red shifted fluorescent proteins
10/31/2002	US20020160472 Coupling drug to glycidyl methacrylate-styrene copolymer
10/31/2002	US20020160463 Phagemid for antibody screening
10/31/2002	US20020160458 Gene expression of endoprotease in eukaryotic cells; yeast culture product
10/31/2002	US20020160457 Immobilizated antigens; cloning gene sequence; electroporation; calibration
10/31/2002	US20020160456 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/31/2002	US20020160454 Biosynthesis of polynucleotides using amplification primers
10/31/2002	US20020160453 Novel gene encoding a sodium channel beta-3 subunit protein
10/31/2002	US20020160451 Isolated nucleic acids; genetic engineering
10/31/2002	US20020160450 Methods and compositions for increasing protein yield from a cell culture
10/31/2002	US20020160449 Human vomeronasal receptor
10/31/2002	US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002	US20020160447 Ups (ugc)
10/31/2002	US20020160446 Novel genes encoding proteins having prognostic diagnostic preventive therapeutic and other uses
10/31/2002	US20020160441 Protein elongation factor 2 as a target for antifungal and antiparasitic agents
10/31/2002	US20020160433 Diagnosis of urogenital disorders
10/31/2002	US20020160432 Quantitative analysis; diagnosis of infections
10/31/2002	US20020160429 Using antibody released by hybridomas cells
10/31/2002	US20020160424 T1R hetero-oligomeric taste receptors
10/31/2002	US20020160416 Receptor from TNF family
10/31/2002	US20020160414 Immune cell cytokine

1 ... 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 ... 2916